The Top Analysis for AbbVie, Inc. (ABBV)
The top analysis was written by Dividend Diplomats Blog titled Dividend Income Summary: Lanny’s November 2022 Summary
Is AbbVie, Inc. (ABBV) a buy?Based on 7 suggestions, AbbVie, Inc.(ABBV) is recommended as a STRONG BUY at $138.96.
Are These Ratings Good?Based on 7 ratings, the average Return is -0.21%.
Forecast for AbbVie, Inc. (ABBV)
the two year forecast for ABBV is $172.64.
The four year forecast is $206.62